HIV drugs Stories
Gilead is seeking regulatory approval to distribute lenacapavir in additional African countries, including Kenya, Rwanda, Tanzania and Botswana.
Lenacapavir is the first long-acting injectable HIV prevention drug that requires administration only twice a year. It offers a highly effective and c...
Reported data for 2024 shows that 9.2 million people living with HIV were still not accessing life-saving treatment services last year.
Unlike daily PrEP pills or injections given every two months, the shot could be more appealing to people who struggle with adherence or wish to avoid...
U.S. District Judge Zahid Quraishi in Trenton, New Jersey, ordered the drugmaker's Janssen unit to pay $360 million for violating the federal False Cl...
The supplies will be distributed through a partnership with the Mission for Essential Drugs and Supplies, ensuring their efficient delivery to those i...
Despite this progress, experts warn that the current rates are still too high.
The drug, lenacapavir, is administered via an injection twice a year.
